Literature DB >> 18282761

Surgical treatment of pleural recurrence from thymoma.

Marco Lucchi1, Fulvio Basolo, Alfredo Mussi.   

Abstract

A complete surgical resection represents the cornerstone of the therapy of the thymic tumours. Pleural disease may already be present at the diagnosis representing an advanced stage thymoma (Masaoka IVA) or it may appear during the follow-up, representing a pleural recurrence. The treatment of Stage IVA thymoma is quite examined in the medical literature; however just a few reports analysed the surgical treatment of thymoma recurrences, whose exclusive pleural recurrences represent more than 90%. Our aim was to review the literature laying the stress on the incidence, diagnosis, treatment options and prognosis of this highly selected group of patients with pleural recurrence from thymoma.

Entities:  

Mesh:

Year:  2008        PMID: 18282761     DOI: 10.1016/j.ejcts.2008.01.015

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  11 in total

1.  Pleural recurrences of thymoma: role and effectiveness of intrathoracic chemohyperthermia.

Authors:  Giuseppe Marulli; Marco Mammana; Giovanni Maria Comacchio; Federico Rea
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

2.  En bloc extended total thymectomy and extrapleural pneumonectomy in Masaoka stage IVA thymomas.

Authors:  Hee Chul Yang; Yoo Sang Yoon; Hong Kwan Kim; Yong Soo Choi; Kwhanmien Kim; Young Mog Shim; Jungho Han; Jhingook Kim
Journal:  J Cardiothorac Surg       Date:  2011-03-12       Impact factor: 1.637

Review 3.  Treatment of advanced thymoma and thymic carcinoma.

Authors:  Arun Rajan; Giuseppe Giaccone
Journal:  Curr Treat Options Oncol       Date:  2009-04-21

Review 4.  The clinical features, diagnosis and management of recurrent thymoma.

Authors:  Taobo Luo; Hongguang Zhao; Xinming Zhou
Journal:  J Cardiothorac Surg       Date:  2016-08-31       Impact factor: 1.637

5.  Metastatic Thymoma-Associated Myasthenia Gravis: Favorable Response to Steroid Pulse Therapy Plus Immunosuppressive Agent.

Authors:  Guoyan Qi; Peng Liu; Huimin Dong; Shanshan Gu; Hongxia Yang; Yinping Xue
Journal:  Med Sci Monit       Date:  2017-03-09

Review 6.  [Treatment of Recurrent Thymoma].

Authors:  Xianping Liu; Xiao Li; Jianfeng Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-02-27

7.  Extended thymectomy with blood vessel resection and reconstruction improves therapeutic outcome for clinical stage III thymic carcinoma patients: a real-world research.

Authors:  Lei Liu; Jiaqi Zhang; Guige Wang; Chao Guo; Yeye Chen; Cheng Huang; Shanqing Li
Journal:  J Cardiothorac Surg       Date:  2020-09-25       Impact factor: 1.637

8.  Thymoma-associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma.

Authors:  Anna De Rosa; Marco Fornili; Michelangelo Maestri Tassoni; Melania Guida; Laura Baglietto; Loredana Petrucci; Antonio Chella; Franca Melfi; Marco Lucchi; Roberta Ricciardi
Journal:  Thorac Cancer       Date:  2020-11-03       Impact factor: 3.500

Review 9.  The role of surgery in the management of locally advanced and metastatic thymoma: a narrative review.

Authors:  Catherine Wagner; Elliot Wakeam; Shaf Keshavjee
Journal:  Mediastinum       Date:  2021-06-25

Review 10.  Percutaneous Image-Guided Ablation of Lung Tumors.

Authors:  Sadeer J Alzubaidi; Harris Liou; Gia Saini; Nicole Segaran; J Scott Kriegshauser; Sailendra G Naidu; Indravadan J Patel; Rahmi Oklu
Journal:  J Clin Med       Date:  2021-12-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.